Langtong Medical Establishes AI Institute, Deepening Industry-Academia-Research Collaboration

Recently, the Special Seminar on Intelligent Clinical Decision Support Systems and the Unveiling Ceremony for the Establishment of the “Langtong Medical Artificial Intelligence Research Institute” were successfully held in China AI Town. The event was jointly initiated and hosted by Zhejiang University, the Zhejiang Provincial Medical Science and Technology Education Development Center, and Langtong Medical.

Event Venue | China AI Town · Town Living Room

At the meeting,Professor Fang Lizheng, Discipline Leader of General Practice at Zhejiang University; Director Li Zhefeng, Artificial Intelligence Industry Planning, Zhejiang Digital Content Research Institute; Dr. Lin Hui, Deputy Dean of the College of Biomedical Engineering and Instrument Science at Zhejiang University; Professor Huang Zhengxing, College of Computer Science and Technology at Zhejiang University; and Mr. Xu Zhe, Chairman of Langtong MedicalFive invited guests delivered keynote speeches respectively.

In addition, the event was attended by Director Xu Yi of the Institute of Automation, Chinese Academy of Sciences; Director Gao Yanchao of the Zhejiang Provincial Medical Science and Technology Education Development Center; Director Feng Jingyi of the First Affiliated Hospital, Zhejiang University School of Medicine; Director Zhang Junhang of the Mental Health Center Affiliated to Zhejiang University; Mr. Liu Kaixuan from Saizhi Bole; Mr. Jiang Junfeng from Shanghai Guoke Longhui; Dr. Xue Chong from Quanzhen Medicine; and Mr. Lin Junchao from Rongyi Investment.

Special Symposium on Intelligent Clinical Decision Support for Diagnosis and TreatmentThe Special Symposium on Intelligent Clinical Decision Support for Diagnosis and Treatment originated in late 2021, when Zhejiang University, the Zhejiang Medical Science and Technology Education Development Center, and Langtong Medical successfully secured a project under the Zhejiang Provincial Department of Science and Technology’s “Lingyan” (Leading Goose) R&D Key Breakthrough Program for 2022. The 2022 Kick-off Meeting for the Zhejiang Provincial “Lingyan” Project and the Expert Review Meeting on the Implementation Plan were presided over by Dr. Lin Hui, the project leader.

Dr. Lin Hui, Deputy Dean of the College of Biomedical Engineering and Instrument Science, Zhejiang University | Introduction to the 2022 “Lingyan” R&D Key Project

Dr. Lin Hui provided an accessible overview of the Lingyan Project and outlined his expectations. He pointed out that since 2015, it has become an industry consensus that AI’s vertical empowerment of industries is driving the in-depth development of medical services. The emergence of AI has enabled primary care physicians to leverage a “smart stool” built upon the accumulated expertise and knowledge of specialists. Furthermore, the integration of teaching with intelligent systems offers a practical and effective pathway for genuinely enhancing the service capabilities of primary healthcare institutions.

“The “Lingyan” Project primarily anchors itself to the core of the new healthcare reform and a key pillar of Healthy China—the tiered diagnosis and treatment system—focusing on strengthening the foundation to provide robust primary healthcare support for the public.Building on prior achievements, the 2022 “Lingyan” Project primarily represented a self-imposed challenge for the project team members, who set higher standards for the project outcomes in terms of medical breadth and technical depth, such as expanding disease coverage and improving the hit rate of the top three diagnostic predictions.

At the seminar, Director Xu Yi from the Institute of Automation, Chinese Academy of Sciences; Director Gao Yanchao from the Zhejiang Provincial Medical Science and Technology Education Development Center; Director Feng Jingyi from the First Affiliated Hospital, Zhejiang University School of Medicine; Director Zhang Junhang from the Mental Health Center Affiliated to Zhejiang University; Liu Kaixuan from Sai Zhi Bo Le; and Dr. Xue Chong from Quanzhen Medicine participated in reviewing the implementation plan. They provided valuable opinions and suggestions from perspectives including the construction of an application evaluation system, standardization of diagnostic and therapeutic mind maps, general practice exhibitions, residency training activities, translation platforms, product positioning, data source development, and the “diagnosis” and “treatment” aspects of both specialized and general practice.

To further build consensus on the 2022 “Leading Goose” Project of the Department of Science and Technology, and to actively promote the demonstration and application of project outcomes in medical institutions,“Langtong Medical AI Research Institute” was established, marking a new chapter in Langtong Medical’s development journey.

Xu Zhe, Chairman of Langtong Medical, presented appointment letters to the first batch of advisors and visiting researchers at the Langtong Medical Artificial Intelligence Research Institute and delivered a speech. Xu Zhe began by expressing his gratitude for the long-term support from government officials, distinguished guests, and industry experts.

He stated,“Langtong Medical AI Research Institute” is dedicated to building an industry exchange platform and promoting research on how artificial intelligence empowers the healthcare and wellness sector. The Institute aims for its team to seize the opportunities of the era, leverage strengths in medicine, technology, and applications, and actively advance strategic assessment, achievement transformation, and industrial integration. Through continuous exploration and innovation, it strives to deepen the translation and application of research outcomes, contributing collaboratively to the intelligent development of the medical information industry.

Xu Zhe stated that Dr. Huang Zhengxing is an expert in the field of medical artificial intelligence, who has long been dedicated to theoretical research and practical exploration in promoting intelligent clinical decision support systems. He also possesses extensive experience in innovation management and talent development. As a key technical leader at the Langtong Medical Artificial Intelligence Research Institute, Dr. Huang will lead the institute to forge ahead continuously in the realm of AI-plus-healthcare innovation, achieving ongoing breakthroughs and setting new benchmarks.

Xu Yi, Director of the Institute of Automation, Chinese Academy of Sciences; Xu Zhe, Chairman of Langtong Medical

Joint Unveiling Ceremony for the Langtong Medical Research Institute

Langtong Medical Research Institute Appointment Ceremony

Professor Fang Lizheng, Academic Leader of General Practice at Zhejiang University | Reflections on Clinical Decision Support Systems from the Perspective of General Practice

Medical artificial intelligence cannot be separated from medicine; clinical reasoning is the foundation of AI-assisted diagnostic and therapeutic products.Professor Fang Lizheng delivered a presentation titled “Reflections on Clinical Decision Support Systems from the Perspective of General Practice,” tracing the mission of medicine and the current state of general practice, highlighting bottlenecks in disciplinary development, and outlining potential pathways for future growth. The key themes of her talk were “the essence of healthcare, the humanism of medicine, physicians’ compassion, and medical innovation.”

Li Zhefeng, Director of the AI Industry Planning Research Office and Director of the Digital Reform Special Task Force at Zhejiang Institute of Digital Content | The Path to Controllable Autonomous Evolution in the Smart Healthcare Industry

Director Li Zhefeng believes that the development of medical artificial intelligence is still in its early stages, with many gaps ranging from data standards and industry standards to business models. Companies entering this field are not only transforming themselves but also shouldering the mission of reshaping the entire industry.The development of information systems for emerging county-level medical consortia and specialized hospitals serves as an excellent entry point. Meanwhile, the in-depth involvement of medical experts will provide the driving force for AI-driven innovation and transformation in the healthcare sector.

Dr. Huang Zhengxing, Professor at the College of Computer Science and Technology, Zhejiang University | Intelligent Diagnostic and Treatment Decision-Making Technologies

Professor Huang Zhengxing from the College of Computer Science and Technology at Zhejiang University, with his unique perspective, presented innovative achievements and the latest technological insights in the field of international medical informatics, reflecting on the gaps in China from a standpoint of technical rationality. Using the computer-aided diagnosis and treatment project for cardiovascular diseases (which won the First Prize of the PLA’s Science and Technology Progress Award in 2016) as an example, he introduced the iterative improvements made to model samples in areas such as risk warning, intervention recommendation, prognosis analysis, and disease progression.

Xu Zhe, Chairman of Langtong Medical | Practical Applications and Reflections on Intelligent Clinical Decision Support Systems

Xu Zhe, Chairman of Langtong Medical, shared insights and perspectives on Langtong’s practical experience with CDSS systems.Langtong Medical has evolved into a platform supporting multiple product applications, driven by the “Medical Brain Platform” AI middle-end and knowledge middle-end to power diverse upper-layer scenario-based applications.Following the keynote address, the attendees engaged in in-depth discussions on topics including the construction and maintenance of knowledge bases, standards for medical data, and the development of interdisciplinary talent within the industry.

Group Photo of Attending Experts and Guests

In recent years, Longtong Medical has been actively exploring new models for integrating industry, academia, and research. This strategic partnership, characterized by strong alliances and multi-party win-win outcomes, will bring historic development opportunities to Longtong. The establishment of the “Longtong Medical Artificial Intelligence Research Institute” will further deepen collaboration with the Institute of Automation, Chinese Academy of Sciences, and Zhejiang University, elevating the industry-academia-research consortium to a new level.

Langtong Medical, established in 2004, is a high-tech enterprise dedicated to the research and development of medical artificial intelligence products centered on medical text analytics. Headquartered in Hangzhou, Zhejiang Province, the company is committed to providing users with comprehensive, reliable, and authoritative medical decision support services. Leveraging robust foundational AI technologies and an extensive medical knowledge base, its product portfolio covers various healthcare scenarios, including triage, pre-consultation, clinical decision support, and medical record quality control. By delivering an intelligent decision-making “brain” for both patients and hospitals, Langtong Medical empowers healthcare institutions to accelerate their digital and intelligent transformation.